Eastern Virginia Medical School
OrganisationROR
People
Lead investigator
Sources: reporter.nih.gov, openalex.org
Trials
Phase 4, Recruiting, 80 people, 13 Aug 2025
Phase 2, Completed, 330 people, 14 Jul 2022
Phase 4, Status unknown, 60 people, 1 Jun 2021
Early phase 1, Completed, 14 people, 3 May 2021
Phase 2/3, Completed, 52 people, 22 Feb 2018
Collaborator, Phase 1, Completed, 25 people, 30 Mar 2016
Collaborator, Phase 2, Completed, 50 people, 12 Dec 2007
Grants and prizes
National Heart, Lung, and Blood Institute
R01, Epigenetic Modulation of Cellular Senescence in the Cystic Fibrosis Lung, R01HL169253, US$400.3k, 2024, 15 Mar 2024
National Institute of Child Health and Human Development
R00, A-to-I RNA modifications in mouse oocytes, R00HD099269, US$153.3k, 2019–2024, 15 Feb 2024
AHA Institutional Research Enhancement Award, Alveolar cell membrane repair and senescence in lung aging, 20AIREA35120255, US$189k, 2020–2021, 1 Jan 2020
Sources: reporter.nih.gov, openalex.org
Funded papers
Single-cell transcriptomic analysis reveals age-related remodeling of brain endothelial cells
31 Jul 2026
Sources: api.crossref.org
Papers
ADA Scientific Sessions 2025 abstract, 13 Jun 2025